Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera

Aggarwal, 2012, Anti-transcription intermediary factor 1-gamma autoantibody detection by ELISA and immunoprecipitation in a prospective myositis cohort: predictive value for cancer associated myositis

Arnett, 1988, The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum., 31, 315, 10.1002/art.1780310302

Beneviste, 2011, Correlation of antisignal recognition particle autoantibody levels with creatinine kinase activity in patients with necrotizing myopathy, Arthritis Rheum., 63, 1961, 10.1002/art.30344

Bernstein, 1982, Identification of antibodies to acidic antigens by counterimmunoelectrophoresis, Ann. Rheum. Dis., 41, 554, 10.1136/ard.41.5.554

Bohan, 1975, Polymyositis and dermatomyositis (second of two parts), N. Engl. J. Med., 292, 403, 10.1056/NEJM197502202920807

Cavagna, 2015, Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study, Medicine (Baltimore), 94, 10.1097/MD.0000000000001144

Clark, 1969, Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus, J. Immunol., 102, 117, 10.4049/jimmunol.102.1.117

Fiorentino, 2011, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study, J. Am. Acad. Dermatol., 65, 25, 10.1016/j.jaad.2010.09.016

Hall, 2013, Anti-MDA5-associated dermatomyositis: expanding the clinical spectrum, Arthritis Care Res., 65, 1307, 10.1002/acr.21992

Imbert-Maseau, 2003, Antisynthetase syndrome, Joint Bone Spine, 70, 161, 10.1016/S1297-319X(03)00012-5

Jeon, 2013, Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection, Clin. Exp. Rheumatol., 31, 84

Koga, 2012, The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM, Rheumatology, 51, 1278, 10.1093/rheumatology/ker518

Labirua-Iturburu, 2012, Anti-PL-7 (antithreonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature, Medicine, 91, 206, 10.1097/MD.0b013e318260977c

Lega, 2014, The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome, Autoimmun. Rev., 13, 883, 10.1016/j.autrev.2014.03.004

LeRoy, 1988, Scleroderma (systemic sclerosis): classification subsets and pathogenesis, J. Rheumatol., 15, 202

Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogeneous patient groups, Medicine (Baltimore), 70, 360, 10.1097/00005792-199111000-00002

Masi, 1980, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum., 23, 581, 10.1002/art.1780230510

Mathews, 1983, Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity, Nature, 304, 177, 10.1038/304177a0

Meyer, 1987, The principal antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. study of 42 cases, Presse Med., 16, 155

Muro, 2012, Disappearance of anti-MDA-5 autoantibodies in clinical amyopathic DM/interstitial lung disease during disease remission, Rheumatology, 51, 800, 10.1093/rheumatology/ker408

Muro, 2013, A new ELISA for dermatomyositis autoantibodies: rapid introduction of antigen cDNA to recombinant assays for autoantibodies measurement, Clin. Dev. Immunol., 10.1155/2013/856815

Nakashima, 2010, Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies, Int. J. Clin. Rheumatol., 5, 523, 10.2217/ijr.10.48

Nishikai, 1980, Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system, Arthritis Rheum., 23, 881, 10.1002/art.1780230802

Satoh, 2015, A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy, Clin. Rev. Allergy Immunol., 10.1007/s12016-015-8510-y

Stone, 2007, Anti-Jo1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy, Arthritis Rheum., 56, 3125, 10.1002/art.22865

Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 25, 1271, 10.1002/art.1780251101

Tansley, 2013, The diagnostic utility of autoantibodies in adult and juvenile myositis, Curr. Opin. Rheumatol., 25, 772, 10.1097/01.bor.0000434664.37880.ac

Targoff, 1992, Autoantibodies in polymyositis, Rheum. Dis. Clin. N. Am., 18, 455, 10.1016/S0889-857X(21)00737-7

Targoff, 2000, Update on myositis-specific and myositis-associated autoantibodies, Curr. Opin. Rheumatol., 12, 475, 10.1097/00002281-200011000-00001

Venables, 1983, Purification and characterization of the Sjögren's Syndrome A and B antigens, Clin. Exp. Immunol., 54, 731

Vitali, 2002, Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group, Ann. Rheum. Dis., 61, 554, 10.1136/ard.61.6.554

Yamasaki, 2006, Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases, Arthritis Res. Ther., 8, R111, 10.1186/ar2000